• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL PUERTO RICO, INC. SJM REGENT HEART VALVE; HEART-VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL PUERTO RICO, INC. SJM REGENT HEART VALVE; HEART-VALVE, MECHANICAL Back to Search Results
Model Number 23AGN-751
Device Problem Degraded (1153)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/11/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).
 
Event Description
In 2009, a 23mm regent heart valve was implanted in the aortic position.On (b)(6) 2016, a double valve replacement procedure was performed and the regent valve was explanted as it was reported one of the leaflets was immobile and in the open position in situ.A reason for the immobile leaflet was not found and details regarding the second valve that was explanted are unknown.Ex vivo, the regent valve's leaflets were mobile.A 23mm trifecta valve was implanted.
 
Manufacturer Narrative
The results of this investigation concluded there was fibrous pannus ingrowth on the inflow surface with microcalcifications, which resulted in the narrowing of the inflow diameter.The leaflets were able to close and open completely and easily.No inflammation was present on the valve.A review of the device history record showed the device met specifications prior to leaving sjm manufacturing facilities.There was no evidence found to suggest the cause of the fibrin, pannus or calcifications were due to an intrinsic defect in the valve, as supported by review of the valve's device history record and the analysis performed.The cause of the reported event remains unknown.
 
Event Description
In 2009, a 23mm regent heart valve was implanted in the aortic position.On (b)(6) 2016, the regent valve was explanted as it was reported one of the leaflets was immobile and in the open position in situ.A reason for the immobile leaflet was not found although the physician suspected it may have been due to the position of the mitral valve.Ex vivo, the regent valve's leaflets were mobile.A 23mm trifecta valve was implanted.Concomitantly, the native mitral valve was replaced with a prosthetic valve.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM REGENT HEART VALVE
Type of Device
HEART-VALVE, MECHANICAL
Manufacturer (Section D)
ST. JUDE MEDICAL PUERTO RICO, INC.
p.o. box 998
lot 20 b st.
caguas, puerto rico 00725
Manufacturer (Section G)
ST. JUDE MEDICAL PUERTO RICO, INC.
p.o. box 998
lot 20 b st.
caguas, puerto rico 00725
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517564470
MDR Report Key5697644
MDR Text Key46503746
Report Number2648612-2016-00052
Device Sequence Number1
Product Code LWQ
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P810002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/17/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/03/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date04/07/2014
Device Model Number23AGN-751
Device Catalogue Number23AGN-751
Device Lot Number2968758
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/14/2016
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/17/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/15/2009
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age70 YR
-
-